AlivaMab Discovery Services
Omer Keinan is a dedicated scientist currently engaged in therapeutic antibody discovery and assay development at AlivaMab Biologics since July 2021. Prior to this role, Omer served as a postdoctoral fellow at the University of California, San Diego, from November 2015 to July 2021, focusing on the role of glycogen metabolism in adipose tissue thermogenesis. Omer's academic background includes a significant tenure at the Weizmann Institute of Science, where Omer conducted doctoral research under the supervision of distinguished mentors, culminating in a Ph.D. in cancer cell biology in 2014. Omer's research also extends to postdoctoral work at the Weizmann Institute, investigating the impact of Nir2 and Nir3 on cytoskeleton remodeling and breast cancer metastasis.
This person is not in any teams
AlivaMab Discovery Services
AlivaMab Discovery Services is a leader in the discovery of antibody therapeutics, trusted by top-tier pharmaceutical and biotechnology companies to deliver panels of drug-quality human antibodies.